BioSpace News Archive

BioCapital

NeuralStem Inc. Added To Russell 3000 Index

June 30, 2014
·
3 min read
Mainstay Medical Announces Expansion Of Clinical Trial Of ReActiv8® For People With Chronic Low Back Pain To Belgium

June 30, 2014
·
3 min read
Drug Development

Mologen AG: Cancer Immune Therapy MGN1703 Shows Outstanding Long-Term Responses

June 30, 2014
·
7 min read
Genetown

InVivo Therapeutics CorporationTo Present At 4th International Neural Regeneration Symposium In China

June 30, 2014
·
1 min read
Business

CAPNIA, Inc. Appoints William G. Harris To Its Board Of Directors

June 30, 2014
·
4 min read
Isogenica Secure Funding from UK’s Technology Strategy Board To Develop Gene Library Synthesis For Synthetic Biology

June 30, 2014
·
3 min read
Drug Development

Icon Bioscience Announces Early Completion Of Patient Enrollment In Its Phase 3 Study Of IBI-10090; Drug Addresses Market Need For Long-Acting Treatment Of Inflammation Post Cataract Surgery

June 30, 2014
·
1 min read
Pharm Country

Actinium Pharmaceuticals, Inc. Closes Public Offering Of Common Shares

June 30, 2014
·
1 min read
Genetown

Alnylam Pharmaceuticals Added To Russell 1000 Index As A Member Of The Large-Cap Segment Of The U.S. Equity Universe

June 30, 2014
·
1 min read
Drug Development

Veloxis Pharmaceuticals A/S Release: Envarsus® XR Demonstrates Lower Treatment Failure Rate In African-Americans Compared To Twice-Daily Tacrolimus (Prograf®)

June 30, 2014
·
5 min read